{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:21:19Z","timestamp":1794853279912,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001734","name":"University of Copenhagen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Phospholipid Research Center Heidelberg"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijpharm.2016.02.026","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T18:19:44Z","timestamp":1456165184000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine"],"prefix":"10.1016","volume":"502","author":[{"given":"Thuy","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.02.026_bib0005","series-title":"Surfactant Systems: Their Chemistry, Pharmacy and Biology","first-page":"617","article-title":"Aspects of surfactant toxicity","author":"Attwood","year":"1983"},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstrom","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.02.026_bib0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2009.10.005","article-title":"Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics","volume":"142","author":"Buyukozturk","year":"2010","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ijpharm.2016.02.026_bib0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V","article-title":"Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats","volume":"89","author":"Caliph","year":"2000","journal-title":"J. Pharm Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.02.026_bib0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.ph.45.030183.003251","article-title":"Lipid digestion and absorption","volume":"45","author":"Carey","year":"1983","journal-title":"Annu. Rev. Physiol."},{"issue":"2","key":"10.1016\/j.ijpharm.2016.02.026_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.20780","article-title":"Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro\/in vivo case studies","volume":"96","author":"Constantinides","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0035","series-title":"Design of Experiments: Principles and Applications","author":"Eriksson","year":"2008"},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0040","series-title":"Food Hydrocolloids: Structures, Properties, and Functions","first-page":"429","article-title":"Enhanced emulsifying ability of food surfactants by addition of lysophospholipids","author":"Fujita","year":"1993"},{"issue":"5","key":"10.1016\/j.ijpharm.2016.02.026_bib0045","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.02.026_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00330108","article-title":"Toxicological properties of surfactants","volume":"32","author":"Gloxhuber","year":"1974","journal-title":"Arch. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2016.02.026_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cocis.2009.11.006","article-title":"The influence of emulsion structure and stability on lipid digestion","volume":"15","author":"Golding","year":"2010","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"10","key":"10.1016\/j.ijpharm.2016.02.026_bib0060","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1002\/jps.22151","article-title":"Soft gelatin capsules (softgels)","volume":"99","author":"Gullapalli","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.02.026_bib0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.colsurfa.2011.09.048","article-title":"Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation","volume":"392","author":"Gupta","year":"2011","journal-title":"Colloids Surf. A"},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0070","series-title":"A Guide to Phospholipid Chemistry","first-page":"61","article-title":"Choline-containing phospholipids: diacyl-, alkylacyl-, and alkenylacylcholine phosphoglycerides and sphingomyelin","author":"Hanahan","year":"1997"},{"issue":"2","key":"10.1016\/j.ijpharm.2016.02.026_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00232-T","article-title":"Drug delivery studies in Caco-2 monolayers. II. Absorption enhancer effects of lysophosphatidylcholines","volume":"114","author":"Hovgaard","year":"1995","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.02.026_bib0080","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jps.2600830336","article-title":"Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation","volume":"83","author":"Kovarik","year":"1994","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2016.02.026_bib0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejps.2012.11.004","article-title":"Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation","volume":"48","author":"Larsen","year":"2013","journal-title":"Eur. J. Pharm Sci."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.02.026_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.02.026_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-7439(98)00065-3","article-title":"Experimental design and optimization","volume":"42","author":"Lundstedt","year":"1998","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0105","doi-asserted-by":"crossref","unstructured":"Madsen, C.M., Boyd, B., M\u00fcllertz, A., Rades, T., 2016 Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Unpublished manuscript.","DOI":"10.1016\/j.ejps.2016.05.026"},{"issue":"2","key":"10.1016\/j.ijpharm.2016.02.026_bib0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejpb.2007.12.020","article-title":"Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state","volume":"69","author":"Nielsen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.ijpharm.2016.02.026_bib0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1517\/17425250903176439","article-title":"The effect of oral lipids and circulating lipoproteins on the metabolism of drugs","volume":"5","author":"Patel","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0120","series-title":"Pharmaceutical Capsules","author":"Podczeck","year":"2004"},{"issue":"3","key":"10.1016\/j.ijpharm.2016.02.026_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2016.02.026_bib0130","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.02.026_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02915334","article-title":"A classification of biologic lipids based upon their interaction in aqueous systems","volume":"45","author":"Small","year":"1968","journal-title":"J. Am. Oil Chem. Soc."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.02.026_bib0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/gut.26.4.369","article-title":"Lysophosphatidylcholine increases rat ileal permeability to macromolecules","volume":"26","author":"Tagesson","year":"1985","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ijpharm.2016.02.026_bib0145","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jps.23054","article-title":"Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems","volume":"101","author":"Thomas","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-024921-3.50011-3","article-title":"Gastrointestinal digestion and absorption of lipid","volume":"21","author":"Tso","year":"1985","journal-title":"Adv. Lipid Res."},{"issue":"5","key":"10.1016\/j.ijpharm.2016.02.026_bib0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11894-999-0022-6","article-title":"The ileal brake: a fifteen-year progress report","volume":"1","author":"Van Citters","year":"1999","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"9","key":"10.1016\/j.ijpharm.2016.02.026_bib0160","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.02.026_bib0165","series-title":"3D QSAR in Drug Design: Volume 1: Theory Methods and Applications","first-page":"523","article-title":"PLS-Partial least-square projections to latent structures","author":"Wold","year":"1993"}],"updated-by":[{"DOI":"10.1016\/j.ijpharm.2016.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000}}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316301193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316301193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:30:57Z","timestamp":1759915857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316301193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0378517316301193"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.02.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}